Akarakarabha vati in the management of erectile dysfunction

An open lable single arm clinical study on the effectiveness of Akarakarabha vati in the management of Klaibya (Erectile dysfunction)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031047

Enrollment

Registered

2021-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N529- Male erectile dysfunction, unspecified

Interventions

Intervention1: Vati - Akarakarabha vati : Dose - 500 mg twice a day after food Anupana - warm milk Duration - 30 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Minimum 3 months history of erectile dysfunction. 2. Age-25 to 60 years. 3. Fairly good glycemic condition (DMT2). 4. Those subjects ready to participate and follow the instruction and Â Â Â Â sign the informed consent form.

Exclusion criteria

Exclusion criteria: Subjects with, 1. K/C/O essential hypertension and cardiac, hepatic, renal disorders 2. Significant anatomical penile deformity 3. History of prostatectomy or penile implant

Design outcomes

Primary

Measure	Time frame
Improvement in penile erection, rigidty, sexual desireTimepoint: 45 days	—

Secondary

Measure	Time frame
Increase in semen countTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Girish K J

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

girideepa@yahoo.co.in9448646855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026